BROKER MOVES: MRNA upgraded at Argus; ALL downgraded at Argus
Broker actions include Argus upgrading Moderna to Buy with a USD 180 price target and downgrading Allstate to Hold, alongside multiple other rating changes across Wall Street.
News detail
UPGRADES Baozun (BZUN) Upgraded from Hold to Outperform at CLSA; PT USD 3.80 Evolution Petroleum (EPM) Upgraded from Market Perform to Outperform at Northland Element Solutions (ESI) Upgraded from Hold to Buy at Freedom Broker; PT USD 48 Moderna (MRNA) Upgraded from Hold to Buy at Argus; PT USD 180 Petrobras (PBR) Upgraded from Neutral to Outperform at Bradesco BBI; PT USD 20 DOWNGRADES Allstate (ALL) Downgraded from Buy to Hold at Argus VTEX (VTEX) Downgraded from Overweight to Equalweight at Morgan Stanley; PT USD 4 Workday (WDAY) Downgraded from Overweight to Equal-weight at Capital One; PT USD 219 INITIATIONS CV (CV) Initiated at Buy at Roth; PT USD 9 Overseas Shipholding Group (OSG) Initiated at Outperform at Keefe, Bruyette & Woods; PT USD 8 TeraWulf (WULF) Initiated at Outperform at William Blair
Related stocks
9 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
